Coming Soon | GenomeWeb

Coming Soon

In the wake of the Supreme Court ruling last week that invalidated patents on isolated gene sequences held by Myriad Genetics, a number of companies are jumping in to offer BRCA1 and BRCA2 testing. Pharmacogenomics Reporter notes that Ambry Genetics, GeneDx, Gene by Gene, Pathway Genomics, and the University of Washington have said that they will be launching BRCA gene tests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.